In a mesothelioma model, pretreatment of tumors with cisplatin increased gene expression of IFNγ and granzyme B, which could be further increased by subsequent α-GalCer administration, resulting in increased tumor regression [131]. The gene discussed is IFNG; the disease is neoplasm.